B. Braun Melsungen AG Company Profile
The company's Aesculap division provides products for general surgery, orthopedic joint replacement, regenerative therapy, and neurosurgery. It also offers laparoscopy and interventional vascular diagnostics, treatment, degenerative spinal surgery, and cardiothoracic surgeries. The company's Out-Patient Market division offers various services in the areas of ointment prevention, diabetes, incontinence, urology, stoma, and wound management. This includes services for private practitioners, outpatient and inpatient care, pharmacies, and pharmacists.
B. Braun Melsungen AG
Healthcare Industry
- Type
Public
- Headquarters
Germany
- Establishment
1839
- Key Management
Mr. Jean-Claude Dubacher (CEO & Chairman)
- Revenue
~ 8,195.59 (2021)
- Headcount
~ 66,234 (2021)
- Website
Business Description
B. Braun Melsungen AG and its subsidiaries manufacture, market, and sell various healthcare products and services worldwide in the areas of anesthesia, intensive, cardiology, and extracorporeal blood therapy. Hospital Care is the company’s division that offers infusion, nutrition, and pain therapy products. These include infusion and nutrition strategies and medications; products to prepare medications, patient access, administration process, and discharge management products; infusion equipment and supplies; infusion and injection solution, intravenous catheters, clinical nutritional products, pumps, and associated systems for inpatient or outpatient care.
The company’s B. Braun Avitum division provides products in the areas of hemodialysis, acute dialysis, and apheresis to chronic and acute renal failure. The division operates a network with 350 dialysis centers across Europe, Asia, and Latin America. The company was established in Melsungen in Germany in 1839. B. Braun Melsungen AG, a subsidiary of B. Braun Holding GmbH & Co. KG
Key Financials
Revenue (US$ Mn):
- B. Braun Melsungen AG’s annual revenue for 2021 was US$ 8,196 Mn, a -10.15% decrease from 2020
- The annual revenue generated by B. Braun Melsungen AG in 2020 was US$ 9,121 Mn
- At a 2.65% increase, B. Braun Melsungen AG’s annual revenue of US$ 8,368 Mn was indexed in 2019
- B. Braun Melsungen AG generated a total revenue of US$ 8,152 Mn in 2018
Operating Income (US$ Mn):
- US$ 426 Mn was B. Braun Melsungen AG’s operating income in 2021, a -16.63% decrease from 2020 figures
- B. Braun Melsungen AG indexed a 4.95% increase in operating incomes from 2019, amounting to US$ 511 Mn in 2020
- B. Braun Melsungen AG generated a operating income of US$ 487 Mn in 2019
- An operating income of US$ 585 Mn was indexed by Microsoft Corporation in 2018
Net Income (US$ Mn):
- US$ 313 Mn was the net income generated by B. Braun Melsungen AG in 2021
- B. Braun Melsungen AG’s net income for 2020 was US$ 370 Mn, a 67.59% increase from 2019
- From 2018’s net incomes, B. Braun Melsungen AG registered a -42.98% decrease in 2019, amounting to US$ 221 Mn
- A net income of US$ 388 Mn was generated in 2018 by B. Braun Melsungen AG
Operating Margin %:
- B. Braun Melsungen AG’s operating margin for 2021 was 5%, a -8.93% decrease from 2020
- The operating margin generated by B. Braun Melsungen AG in 2020 was 6%
- At a -19.44% decrease, B. Braun Melsungen AG’s operating margin of 6% was indexed in 2019
- B. Braun Melsungen AG generated a operating margin of 7% in 2018
Gross Margin %:
- 4% was B. Braun Melsungen AG’s gross margin in 2021, a -6.17% decrease from 2020 figures
- B. Braun Melsungen AG indexed a 55.77% increase in gross margins from 2019, amounting to 4% in 2020
- B. Braun Melsungen AG generated a gross margin of 3% in 2019
- A gross margin of 5% was indexed by Microsoft Corporation in 2018
SWOT Analysis
Strengths
A comprehensive product and service portfolio that provides a leadership position
B. Braun’s extensive product and service portfolio has helped it become one of the top medical equipment suppliers worldwide to hospitals and other healthcare providers. Braun focuses on hospitals, doctor practices, pharmacies, and nursing homes. It also provides home healthcare services. Its product range includes intravenous products, syringe pumps, accessories for intravenous treatment, intensive care, anesthesia, surgical instruments, sutures, hip and knee prostheses, equipment for extracorporeal bleeding treatment, and wound care products. B. Braun offers more than 5,000 products. Nearly all of these are made by the company. The company also offers consulting services.
Presence in diverse markets helps B. Braun reduces dependency risk
B. Braun is present in many global markets. Braun operates in 64 countries across North America and Latin America. The company earned 16.8% of its total revenues from Germany in FY2018 and 32.9% from other European countries. North America accounted for 23.1%, Latin America (6%), and Africa and the Middle East (3.1%) of total international revenue. B. Braun’s presence in a variety of markets geographically protects it and its revenues from any economic downturn.
Get this premium content
